Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A multi-institutional survey of the quality of life after treatment for uterine cervical cancer: a comparison between radical radiotherapy and surgery in Japan.
Kaneyasu Y, Fujiwara H, Nishimura T, Sakurai H, Kazumoto T, Ikushima H, Uno T, Tokumaru S, Harima Y, Gomi H, Toita T, Kita M, Noda SE, Takahashi T, Kato S, Ohkawa A, Tozawa-Ono A, Ushijima H, Hasumi Y, Hirashima Y, Niibe Y, Nakagawa T, Akita T, Tanaka J, Ohno T; Working Group of the Gynecological Tumor Committee of the Japanese Radiation Oncology Study Group (JROSG). Kaneyasu Y, et al. Among authors: hasumi y. J Radiat Res. 2021 Mar 10;62(2):269-284. doi: 10.1093/jrr/rraa107. J Radiat Res. 2021. PMID: 33415337 Free PMC article.
Dummy-run for standardizing plan quality of intensity-modulated radiotherapy for postoperative uterine cervical cancer: Japan Clinical Oncology Group study (JCOG1402).
Okamoto H, Murakami N, Isohashi F, Kasamatsu T, Hasumi Y, Iijima K, Nishioka S, Nakamura S, Nakamura M, Nishio T, Igaki H, Nakayama Y, Itami J, Ishikura S, Nishimura Y, Toita T. Okamoto H, et al. Among authors: hasumi y. Radiat Oncol. 2019 Jul 29;14(1):133. doi: 10.1186/s13014-019-1340-y. Radiat Oncol. 2019. PMID: 31358026 Free PMC article.
Single-arm confirmatory trial of postoperative concurrent chemoradiotherapy using intensity modulated radiation therapy for patients with high-risk uterine cervical cancer: Japan Clinical Oncology Group study (JCOG1402).
Murakami N, Isohashi F, Hasumi Y, Kasamatsu T, Okamoto H, Nakamura K, Shibata T, Ito Y, Ishikura S, Nishimura Y, Yaegashi N, Toita T. Murakami N, et al. Among authors: hasumi y. Jpn J Clin Oncol. 2019 Sep 1;49(9):881-885. doi: 10.1093/jjco/hyz098. Jpn J Clin Oncol. 2019. PMID: 31613355 Clinical Trial.
A multi-institutional observational study on the effects of three-dimensional radiotherapy and weekly 40-mg/m2 cisplatin on postoperative uterine cervical cancer patients with high-risk prognostic factors.
Isohashi F, Takano T, Onuki M, Arimoto T, Kawamura N, Hara R, Kawano Y, Ota Y, Inokuchi H, Shinjo H, Saito T, Fujiwara S, Sawasaki T, Ando K, Horie K, Okamoto H, Murakami N, Hasumi Y, Kasamatsu T, Toita T. Isohashi F, et al. Among authors: hasumi y. Int J Clin Oncol. 2019 May;24(5):575-582. doi: 10.1007/s10147-018-01380-z. Epub 2018 Dec 22. Int J Clin Oncol. 2019. PMID: 30580379 Free PMC article.
Prognostic factors and optimal therapy for stages I-II neuroendocrine carcinomas of the uterine cervix: A multi-center retrospective study.
Ishikawa M, Kasamatsu T, Tsuda H, Fukunaga M, Sakamoto A, Kaku T, Nakanishi T, Hasumi Y, Iwata T, Baba T, Nogawa T, Kudaka W, Kaneda H, Ono S, Saito F, Taniguchi Y, Okada S, Mizuno M, Onda T, Yaegashi N. Ishikawa M, et al. Among authors: hasumi y. Gynecol Oncol. 2018 Jan;148(1):139-146. doi: 10.1016/j.ygyno.2017.10.027. Epub 2017 Nov 4. Gynecol Oncol. 2018. PMID: 29113721
Radical hysterectomy with or without para-aortic lymphadenectomy for patients with stage IB2, IIA2, and IIB cervical cancer: outcomes for a series of 308 patients.
Tsuruga T, Fujimoto A, Kawana K, Mori M, Hasumi Y, Kino N, Tomio K, Miura S, Tanikawa M, Sone K, Miyamoto Y, Ikeda Y, Kojima S, Adachi K, Nagasaka K, Matsumoto Y, Arimoto T, Oda K, Nakagawa S, Horie K, Yasugi T, Yokota H, Osuga Y, Fujii T. Tsuruga T, et al. Among authors: hasumi y. Int J Clin Oncol. 2016 Apr;21(2):359-366. doi: 10.1007/s10147-015-0907-3. Epub 2015 Oct 5. Int J Clin Oncol. 2016. PMID: 26438230
Stage III disease of ovarian, tubal and peritoneal cancers can be accurately diagnosed with pre-operative CT. Japan Clinical Oncology Group Study JCOG0602.
Onda T, Tanaka YO, Kitai S, Manabe T, Ishikawa M, Hasumi Y, Miyamoto K, Ogawa G, Satoh T, Saito T, Kasamatsu T, Nakanishi T; Japan Clinical Oncology Group. Onda T, et al. Among authors: hasumi y. Jpn J Clin Oncol. 2021 Feb 8;51(2):205-212. doi: 10.1093/jjco/hyaa145. Jpn J Clin Oncol. 2021. PMID: 33556170 Clinical Trial.
Exploration of assistive technology for uniform laparoscopic surgery.
Sato M, Koizumi M, Hino T, Takahashi Y, Nagashima N, Itaoka N, Ueshima C, Nakata M, Hasumi Y. Sato M, et al. Among authors: hasumi y. Asian J Endosc Surg. 2018 Nov;11(4):325-328. doi: 10.1111/ases.12472. Epub 2018 Feb 19. Asian J Endosc Surg. 2018. PMID: 29457703
What is an appropriate second-line regimen for recurrent endometrial cancer? Ancillary analysis of the SGSG012/GOTIC004/Intergroup study.
Nagao S, Nishio S, Okada S, Otsuki T, Fujiwara K, Tanabe H, Takano M, Hasumi Y, Takei Y, Hasegawa T, Matsumoto T, Fujiwara K, Takekuma M, Nakamura K, Shimada M, Suzuki M, Kigawa J. Nagao S, et al. Among authors: hasumi y. Cancer Chemother Pharmacol. 2015 Aug;76(2):335-42. doi: 10.1007/s00280-015-2793-9. Epub 2015 Jun 20. Cancer Chemother Pharmacol. 2015. PMID: 26092322
69 results